Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 532649 | NSE Symbol : NECLIFE | ISIN : INE023H01027 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
24-Jan-2025	31-Jan-2025	Accounts	NECTAR LIFESCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2025 inter alia to consider and approve Financial Results for the quarter and nine months ended on December 31 2024 and Other Business Matters. Outcome of Board Meeting (As per BSE Announcement Dated on 31/01/2025)
04-Nov-2024	14-Nov-2024	Quarterly Results	NECTAR LIFESCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve the Financial Results for the quarter and half year ended on September 30 2024 and other business matters. Outcome of Board Meeting dated November 14, 2024 (As Per Bse Announcement Dated on 14.11.2024)
03-Aug-2024	14-Aug-2024	Quarterly Results	NECTAR LIFESCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve We wish to inform you that a meeting of the Board of Directors of the company will be held on Wednesday August 14 2024 to consider and approve inter alia amongst other items: 1. the Unaudited Financial Results for the quarter ended on June 30 2024 and matters related thereto; and 2. to convene the Annual General Meeting on September 21 2024 and matters related thereto. Please find attached herewith the financial results for the quarter ended on June 30, 2024 (As Per BSE Announcement Dated on 14.08.2024)
08-May-2024	15-May-2024	Accounts	NECTAR LIFESCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2024 inter alia to consider and approve the Audited Financial Results for the Financial Year 2023-24 Financial Statements of the Company for the Financial Year 2023-24 and matters related thereto. Audited Financial Results and outcome of Board Meeting Outcome of Board Meeting - Reappointment of Cost Auditors and Secretarial Auditors (As Per BSE Announcement dated on 15.05.2024)
31-Jan-2024	14-Feb-2024	Quarterly Results	NECTAR LIFESCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve Financial Results for the quarter and nine months ended on December 31 2023 and other business matters. Please find attached herewith Unaudited Financial Results for period ended on December 31, 2023. (As Per BSE Announcement Dated on 14/02/2024)
03-Nov-2023	10-Nov-2023	Quarterly Results	NECTAR LIFESCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve the financial Results for the quarter and half year ended on September 30 2023 and other business matters. Please find attached herewith Unaudited Financial Results for the period ended on September 30, 2023. (As Per BSE Announcement Dated on 10.11.2023)
05-Aug-2023	14-Aug-2023	Quarterly Results	NECTAR LIFESCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 inter alia to consider and approve the financial results for the period ended Jun 30 2023 and other business matters Please find attached herewith the financial results for the period ended on June 30, 2023 Re-appointment of M/s. SMMP and Company, Chartered Accountant, FRN: 120438W as statutory auditor of the company NECLIFE : Nectar Lifesciences Limited has informed the Exchange regarding Board meeting held on August 14, 2023 vide which the Board has 1. amended the Code of Practice and Procedures for Fair Disclosure of Unpublished Price Sensitive Information (UPSI) as required under regulation 8 of SEBI (Prohibition of Insider Trading) Regulations. The amended policy has been updated on the website of the Company at https://www.neclife.com/about-3-5. We are enclosing the amended code of fair disclosure of UPSI adopted by the Company for your records; 2. amended the Materiality of Information Policy as per provisions of extant LODR Regulations. The amended policy has been updated on the website of the Company at https://www.neclife.com/about-3-5 . The details of Key Managerial Personnel ('KMP') authorized for the purpose of determining materiality of an event/information is attached. (As Per BSE Announcement Dated on 14.08.2023)
19-May-2023	26-May-2023	Accounts	NECTAR LIFESCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2023 inter alia to consider and approve We wish to inform you that a meeting of the Board of Directors of the company will be held on Friday May 26 2023 to consider and approve inter alia amongst items: 1. The Audited Financial Results for the Financial Year 2022-23 Financial Statements of the Company for the Financial Year 2022-23 and matters related thereto. 2. To Convene the Annual General Meeting of Members of the Company for the Financial Year 2022-23 and matters related thereto. 3. To fix Book Closure dates for the purpose of Annual General Meeting. We wish to inform you that the Board of Directors in their meeting held on May 26, 2023 have inter- alia decided and approved the following: Audited Financial Results: Pursuant to the Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''LODR Regulation'') the following documents are enclosed: Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2023; Auditors'' Reports thereon; Statement of Assets and Liabilities (Standalone and Consolidated) as at March 31, 2023; Cash Flow Statement (Standalone and Consolidated) for the year ended March 31, 2023; Certificate for unmodified opinion.; (As Per BSE Announcement dated on 26.05.2023)
06-Feb-2023	14-Feb-2023	Quarterly Results	NECTAR LIFESCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve Pursuant to Regulations 29 30 33 and other applicable Regulations of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the company will be held on Tuesday February 14 2023 to consider and approve inter alia amongst items the Unaudited Financial Results for the period ended on December 31 2022. The Unaudited Standalone and Consolidated Financial Results for the quarter and nine months period ended December 31, 2022, which are enclosed herewith along with the Limited Review Reports of the Auditors thereon. Appointment of Ms. Neha Vaishnav as the Company Secretary of the Company w.e.f. February 14, 2023 (As per BSE Announcement Dated on 14/02/2023)
07-Nov-2022	14-Nov-2022	Quarterly Results	NECTAR LIFESCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 inter alia to consider and approve Pursuant to Regulations 29 30 33 and other applicable Regulations of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the company will be held on Monday November 14 2022 to consider and approve inter alia amongst items the Unaudited Financial Results for the quarter and period ended on September 30 2022. Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that: 1. The Board of Directors in their meeting held on November 14, 2022, have appointed Mr. Sushil Kapoor as a Chief Financial Officer ('CFO') of the Company. 2. Mr. Sandeep Goel has resigned from the post of CFO of the Company with effect from November 14, 2022. 3. Ms. Anubha has resigned from the post of Company Secretary and Compliance Officer of the Company with effect from November 15, 2022. This is for your information and record please. We wish to inform you that the Board of Directors in their meeting held on November 14, 2022, have inter-alia decided, approved: 1. and took on record the limited reviewed Unaudited Standalone and Consolidated Financial results for the quarter and period ended on September 30, 2022, which are enclosed herewith along with the Limited Review Reports of the Auditors thereon; 2. to amend the Code of Conduct for Prevention of Insider Trading to keep it in line with amended laws. The amended code has been updated on the website of the company at https://www.neclife.com/about-3-5; 3. to seek approval of shareholders through postal ballot process for: (i) Appointment of Mr. Puneet Sud as a Director of the company liable to retire by rotation (Ordinary Resolution); (ii) Appointment of Mr. Puneet Sud as a Whole time Director designated as a Director (Operations) of the company and to hold office for a period of two years (Special Resolution). (As Per BSE Announcement Dated on 14/11/2022)
24-Sep-2022	24-Sep-2022	Change in Directors	We wish to inform you that the Board of Directors in their meeting held on September 24, 2022 have inter-alia decided and approved to appoint Mr. Puneet Sud (DIN 09735713) as an Additional Director on the Board. He has also been appointed as a Wholetime Director designated as Director (Operations) of the Company for a period of 2 years from September 24, 2022.
06-Aug-2022	13-Aug-2022	Quarterly Results	NECTAR LIFESCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2022 inter alia to consider and approve amongst items the Unaudited Financial Results for the quarter ended on June 30 2022. Limited reviewed Unaudited Standalone & Consolidated Financial results for the quarter ended on June 30, 2022, which are enclosed herewith along with the Limited Review Reports of the Auditors thereon We wish to inform you that the Board of Directors in their meeting held on August 13, 2022 have approved to appoint Dr. Sanjit Singh Lamba (DIN 01741827) as an Additional Director on the Board. He has also been appointed as a Wholetime Director designated as Director (Technical) of the company for a period of 2 years. (As Per BSE Announcement Dated on 13/08/2022)
23-May-2022	30-May-2022	Accounts	NECTAR LIFESCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 inter alia to consider and approve 1. The Audited Financial Results for the Financial Year 2021-22 Financial Statements of the Company for the Financial Year 2021-22 and matters related thereto. 2. To Convene the Annual General Meeting of Members of the Company for the Financial Year 2021-22 and matters related thereto. 3. To fix Book Closure dates for the purpose of Annual General Meeting. Audited Financial Results for the Financial Year 2021-22 and outcome of Board Meeting Board Meeting, inter-alia, has decided that: 1. 27th Annual General Meeting ('AGM') of the Members of the company to be held on Wednesday, September 21, 2022 and matters related thereto. 2. To propose to the members in the forthcoming 27th AGM, to appoint M/s Deepak Jindal & Co, Chartered Accountants as Statutory Auditors of the Company for a term of five years. Details are attached. The Board of Directors in their meeting held on May 30, 2022 have in-principal approved the proposal to sell the Non-Core assets. Details are attached. (As Per BSE Announcement Dated on 30/05/2022)
07-Feb-2022	14-Feb-2022	Quarterly Results	NECTAR LIFESCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 inter alia to consider and approve the Unaudited Financial results for the quarter and nine months ended on December 31 2021. The Board of Directors of the Company at their meeting held today duly approved and took on record the limited reviewed Unaudited Standalone and Consolidated Financial results for the quarter and nine month ended on December 31, 2021, which are enclosed herewith along with the Limited Review Reports of the Auditors thereon. (As Per BSE Announcement Dated 14.02.2022)
03-Nov-2021	13-Nov-2021	Quarterly Results	Quarterly Results The Board of Directors of the Company at their meeting held today duly approved and took on record the limited reviewed Unaudited Standalone and Consolidated Financial results for the quarter and half year ended on September 30, 2021, which are enclosed herewith along with the Limited Review Reports of the Auditors thereon. (As Per BSE Announcement dated on 13.11.2021)

1 2

LOGIN HERE

Nectar Lifescience Ltd

Board Meeting